Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 6 contracts
Samples: Collaboration Agreement (Foundation Medicine, Inc.), Commercialization Agreement (Foundation Medicine, Inc.), Commercialization Agreement (Foundation Medicine, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.120.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 4 contracts
Samples: Collaboration and License Agreement (Blueprint Medicines Corp), License Agreement (C4 Therapeutics, Inc.), License Agreement (C4 Therapeutics, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.117.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 4 contracts
Samples: License Agreement (Dermira, Inc.), License Agreement (Eleven Biotherapeutics, Inc.), License Agreement (Eleven Biotherapeutics, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.115.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerationsconsiderations and as required by Applicable Law, including the rules and regulations pertaining to lcagen under the Securities Exchange Act of 1934, as amended.
Appears in 3 contracts
Samples: License Agreement (Avista Public Acquisition Corp. II), License Agreement (Avista Public Acquisition Corp. II), License Agreement (OmniAb, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure nondisclosure set forth in Section 16.117.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rightsPatent Rights, publications, and certain commercial considerations.. To that end, each Party may disclose Confidential Information to the extent such disclosure is:
Appears in 2 contracts
Samples: Option and License Agreement (Magenta Therapeutics, Inc.), Option and License Agreement (Magenta Therapeutics, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.115.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 2 contracts
Samples: Collaboration and License Agreement (C4 Therapeutics, Inc.), Collaboration and License Agreement (C4 Therapeutics, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.114.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 2 contracts
Samples: License Agreement, License Agreement (Inovio Pharmaceuticals, Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.118.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rightsPatent Rights, publications, and certain commercial considerations.
Appears in 2 contracts
Samples: License Agreement (CinCor Pharma, Inc.), License Agreement (Centessa Pharmaceuticals LTD)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.117.2 (Non-Use and Non-Disclosure), the Parties recognize the need for certain exceptions to this obligation, specifically set forth in Section 17.4 (Press Releases), Section 17.5 (Publications), Section 17.6 (Commercial Considerations), and Section 17.7 (Court or Administrative Order; Compliance with Law) below, with respect to press releases, patent rights, publications, and certain commercial considerations.considerations or court or administrative order, respectively. β
Appears in 1 contract
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.117.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerationsconsiderations or court or administrative order.
Appears in 1 contract
Samples: Research Collaboration and License Agreement (HOOKIPA Pharma Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.120.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rightsPatent Rights, publications, and certain commercial considerations.
Appears in 1 contract
Samples: License and Collaboration Agreement (SQZ Biotechnologies Co)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.117.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rightsPatent Rights, publications, and certain commercial considerations.
Appears in 1 contract
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.121.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 1 contract
Samples: Collaboration and License Agreement (4D Molecular Therapeutics Inc.)
Permitted Disclosure. Notwithstanding the obligation of non-use and non-disclosure set forth in Section 16.113.1, the Parties recognize the need for certain exceptions to this obligation, specifically set forth below, with respect to press releases, patent rights, publications, and certain commercial considerations.
Appears in 1 contract
Samples: Collaboration and License Agreement (Raptor Pharmaceuticals Corp.)
